JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katayama, Y.
Right arrow Articles by Kurachi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katayama, Y.
Right arrow Articles by Kurachi, Y.

Vol. 294, Issue 1, 339-346, July 2000

Inhibitory Effects of Vesnarinone on Cloned Cardiac Delayed Rectifier K+ Channels Expressed in a Mammalian Cell Line

Yusuke Katayama , Akikazu Fujita , Tohru Ohe, Ian Findlay and Yoshihisa Kurachi

Department of Pharmacology II, Faculty of Medicine & Graduate School of Medicine, Osaka University (Y.Ka., A.F., Y.Ku.); Department of Cardiovascular Medicine, Okayama University Medical School (Y.Ka., T.O.); Department of Veterinary Pharmacology, Faculty of Agriculture, Osaka Prefectural University, Osaka, Japan (A.F.); and Centre National de la Recherche Scientifique Unité Mixte de Recherche, Faculty of Science, University of Tours, Tours, France (I.F.)

Vesnarinone, a phosphodiesterase inhibitor, prolongs cardiac action potential duration by inhibiting the delayed rectifier K+ current, IK. We examined the effect of this agent on human ether-a-go-go related gene (HERG) and KvLQT1/minK K+ channels heterologously expressed in human embryonic kidney 293T cells with the whole-cell patch-clamp technique. HERG channel current was inhibited by vesnarinone in a concentration-dependent manner, whereas KvLQT1/minK current was hardly affected by the drug. The inhibition of HERG current by vesnarinone became more prominent and faster as the membrane potential was more depolarized. The properties of inhibition could be described by a first order reaction between the drug and the channel that was apparently independent of HERG channel gating. Although the unbinding rate constant of the drug was constant, the apparent binding rate constant increased as the membrane was more depolarized and the drug concentration was raised. This model also could explain the fast recovery from the drug's effect at hyperpolarized potentials and its rate-dependent inhibition of HERG. Therefore, the effect of vesnarinone on the HERG-K+ current could be adequately described by a simple kinetic model of drug-channel interaction.

0022-3565/00/2941-0339$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
K. Nakamura, Y. Katayama, K. F. Kusano, K. Haraoka, Y. Tani, S. Nagase, H. Morita, D. Miura, Y. Fujimoto, T. Furukawa, et al.
Anti-KCNH2 Antibody-Induced Long QT Syndrome: Novel Acquired Form of Long QT Syndrome
J. Am. Coll. Cardiol., October 30, 2007; 50(18): 1808 - 1809.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Tsujimae, S. Suzuki, S. Murakami, and Y. Kurachi
Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H660 - H669.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. A. Sanchez-Chapula, T. Ferrer, R. A. Navarro-Polanco, and M. C. Sanguinetti
Voltage-Dependent Profile of Human Ether-a-go-go-Related Gene Channel Block Is Influenced by a Single Residue in the S6 Transmembrane Domain
Mol. Pharmacol., May 1, 2003; 63(5): 1051 - 1058.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
W. A. Volberg, B. J. Koci, W. Su, J. Lin, and J. Zhou
Blockade of Human Cardiac Potassium Channel Human Ether-a-go-go-Related Gene (HERG) by Macrolide Antibiotics
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 320 - 327.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. A. Sanchez-Chapula, R. A. Navarro-Polanco, C. Culberson, J. Chen, and M. C. Sanguinetti
Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel Block
J. Biol. Chem., June 21, 2002; 277(26): 23587 - 23595.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Ekins, W. J. Crumb, R. D. Sarazan, J. H. Wikel, and S. A. Wrighton
Three-Dimensional Quantitative Structure-Activity Relationship for Inhibition of Human Ether-a-Go-Go-Related Gene Potassium Channel
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 427 - 434.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. Kamiya, J. S. Mitcheson, K. Yasui, I. Kodama, and M. C. Sanguinetti
Open Channel Block of HERG K+ Channels by Vesnarinone
Mol. Pharmacol., August 1, 2001; 60(2): 244 - 253.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.